Considering the critical roles of IDO1 in cancer metabolism and immune modulation,19 we envisioned that IDO1 holds potential as an effective biomarker to identify the cancer-immune set point, which might help to specify the right patient at the right time for IDO1-blockade combination therapy. The gene discussed is IDO1; the disease is cancer.